Literature DB >> 31852206

New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.

D Michaličková1, M Šíma, O Slanař.   

Abstract

Multiple sclerosis (MS) is an autoimmune neurological disease characterized by chronic inflammation of the central nervous system (CNS), leading to demyelination and axonal damage and resulting in a range of physical, mental or even psychiatric symptoms. Key role of oxidative stress (OS) in the pathogenesis of MS has been suggested, as indicated by the biochemical analysis of cerebrospinal fluid and blood samples, tissue homogenates, and animal models of multiple sclerosis. OS causes demyelination and neurodegeneration directly, by oxidation of lipids, proteins and DNA but also indirectly, by inducing a dysregulation of the immunity and favoring the state of pro-inflammatory response. In this review, we discuss the interrelated mechanisms of the impaired redox signaling, of which the most important are inflammation-induced production of free radicals by activated immune cells and growth factors, release of iron from myelin sheath during demyelination and mitochondrial dysfunction and consequent energy failure and impaired oxidative phosphorylation. Review also provides an overview of the interplay between inflammation, immunity and OS in MS. Finally, this review also points out new potential targets in MS regarding attenuation of OS and inflammatory response in MS.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31852206      PMCID: PMC8565962          DOI: 10.33549/physiolres.934276

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  130 in total

1.  Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.

Authors:  Tomasz Maj; Wei Wang; Joel Crespo; Hongjuan Zhang; Weimin Wang; Shuang Wei; Lili Zhao; Linda Vatan; Irene Shao; Wojciech Szeliga; Costas Lyssiotis; J Rebecca Liu; Ilona Kryczek; Weiping Zou
Journal:  Nat Immunol       Date:  2017-10-30       Impact factor: 25.606

Review 2.  Small Maf proteins (MafF, MafG, MafK): History, structure and function.

Authors:  Fumiki Katsuoka; Masayuki Yamamoto
Journal:  Gene       Date:  2016-04-05       Impact factor: 3.688

Review 3.  Oxidative Stress and the Central Nervous System.

Authors:  Samina Salim
Journal:  J Pharmacol Exp Ther       Date:  2016-10-17       Impact factor: 4.030

Review 4.  Pharmacological applications of antioxidants: lights and shadows.

Authors:  Luciano Saso; Omidreza Firuzi
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

Review 5.  A basic overview of multiple sclerosis immunopathology.

Authors:  N Grigoriadis; V van Pesch
Journal:  Eur J Neurol       Date:  2015-10       Impact factor: 6.089

Review 6.  Cytochrome c: functions beyond respiration.

Authors:  Yong-Ling P Ow; Douglas R Green; Zhenyue Hao; Tak W Mak
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

Review 7.  Iron in multiple sclerosis: roles in neurodegeneration and repair.

Authors:  Erin Stephenson; Nabeela Nathoo; Yasamin Mahjoub; Jeff F Dunn; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

8.  Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.

Authors:  M Adamczyk-Sowa; P Sowa; J Adamczyk; N Niedziela; H Misiolek; M Owczarek; K Zwirska-Korczala
Journal:  J Physiol Pharmacol       Date:  2016-04       Impact factor: 3.011

9.  The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis.

Authors:  Delinda A Johnson; Sara Amirahmadi; Charlotte Ward; Zsuszanna Fabry; Jeffrey A Johnson
Journal:  Toxicol Sci       Date:  2009-11-12       Impact factor: 4.849

Review 10.  NADPH oxidase in brain injury and neurodegenerative disorders.

Authors:  Merry W Ma; Jing Wang; Quanguang Zhang; Ruimin Wang; Krishnan M Dhandapani; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Neurodegener       Date:  2017-01-17       Impact factor: 14.195

View more
  3 in total

Review 1.  Thinking outside the box: non-canonical targets in multiple sclerosis.

Authors:  Laura Bierhansl; Hans-Peter Hartung; Orhan Aktas; Tobias Ruck; Michael Roden; Sven G Meuth
Journal:  Nat Rev Drug Discov       Date:  2022-06-06       Impact factor: 112.288

Review 2.  Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Javier Caballero-Villarraso; Alberto Galván; Eduardo Agüera; Abel Santamaría; Isaac Túnez
Journal:  Inflammopharmacology       Date:  2022-06-05       Impact factor: 5.093

3.  Edaravone attenuates disease severity of experimental auto-immune encephalomyelitis and increases gene expression of Nrf2 and HO-1.

Authors:  Danica Michaličková; Hatice Kübra Öztürk; J Hroudová; M Ľupták; T Kučera; T Hrnčíř; N Kutinová Canová; M Šíma; O Slanař
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.